Biology Reference
In-Depth Information
Ohtomo H (1995) Effect of ibudilast (Ketas) in preventing the recurrence of cerebral infarction.
Yakuri to Rinsho (Jpn Pharmacol Ther) 23:139-157
Ohtsu H, Fujimoto Y, Yamauchi K, Tamura G, Takishima T (1989) Pharmacological effects of
KC-404 on leukotriene release from human leukocytes induced by ionophore A23187. Int Arch
Allergy Appl Immunol 89:306-310
Pag`s L, Gavald` A, Lehner MD (2009) PDE4 inhibitors: a review of current developments
(2005-2009). Expert Opin Ther Pat 19:1501-1519
Peter D, Jin SL, Conti M, Hatzelmann A, Zitt C (2007) Differential expression and function of
phosphodiesterase 4 (PDE4) subtypes in human primary CD4+ T-cells: predominant role of
PDE4D. J Immunol 178:4820-4831
Press NJ, Banner KH (2009) PDE4 inhibitors - a review of the current field. Prog Med Chem 47:
37-74
Rabe KF, Bateman ED, O'Donnell D, Witte S, Bredenbroker D, Bethke TD (2005) Roflumilast -
an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised
controlled trial. Lancet 366:563-571
Rennard SI, Schachter N, Strek M, Rickard K, Amit O (2006) Cilomilast for COPD: results of
a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4.
Chest 129:56-66
Rennard S, Knobil K, Rabe KF, Morris A, Schachter N, Locantore N, Canonica WG,
Zhu Y, Barnhart F (2008) The efficacy and safety of cilomilast in COPD. Drugs 68(Suppl 2):
3-57
Robichaud A, Stamatiou PB, Jin SL, Lachance N, MacDonald D, Lalibert ยด F, Liu S, Huang Z, Conti
M, Chan CC (2002) Deletion of phosphodiesterase 4D in mice shortens alpha(2)-adrenoceptor-
mediated anesthesia, a behavioral correlate of emesis. J Clin Invest 110:1045-1052
Rolan P, Gibbons JA, He L, Chang E, Jones D, Gross MI, Bahr Davidson J, Sanftner LM, Johnson
KW (2008) Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with
single and multiple doses. Br J Clin Pharmacol 66:792-801
Rolan P, Hutchinson MR, Johnson KW (2009) Ibudilast: a review of its pharmacology, efficacy and
safety in respiratory and neurological disease. Expert Opin Pharmacother 10:2897-2904
Rollins BM, Burn M, Coakley RD, Chambers LA, Hirsh AJ, Clunes MT, Lethem MI, Donaldson
SH, Tarran R (2008) A2B adenosine receptors regulate the mucus clearance component of the
lung's innate defense system. Am J Respir Cell Mol Biol 39:190-197
Sanftner LM, Gibbons JA, Gross MI, Suzuki BM, Gaeta FC, Johnson KW (2009) Cross-species
comparisons of the pharmacokinetics of ibudilast. Xenobiotica 39:964-977
Schafer PH, Parton A, Gandhi AK, Capone L, Adams M, Wu L, Bartlett JB, Loveland MA,
Gilhar A, Cheung YF, Baillie GS, Houslay MD, Man HW, Muller GW, Stirling DI (2010)
Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity
in vitro and in a model of psoriasis. Br J Pharmacol 159:842-855
Scott AIF, Perini AF, Shering PA, Whalley LJ (1991) In-patient major depression: is rolipram as
effective as amitryptiline? Eur J Clin Pharamcol 40:127-129
Shinohara Y, Kusunoki T, Nakashima M (2002) Clinical efficacy of ibudilast on vertigo and
dizziness observed in patients with cerebral infarction in the chronic stage - a double-blind,
randomized, placebo-controlled trial with a run-in period. Shinnkeitiryougaku (Neurol Ther)
19:177-187
Singh D, Petavy F, Macdonald AJ, Lazaar AL, O'Connor BJ (2010) The inhaled phosphodiester-
ase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma. Respir Res 11:26
Spina D (2008) PDE4 inhibitors: current status. Br J Pharmacol 155:308-315
Stawiski MA, Rusin LJ, Burns TL, Weinstein GD, Vorhees JJ (1979) Ro 20-1724: an agent that
significantly improves psoriatric lesions in double-blind clinical trials. J Invest Dermatol 73:
261-263
To Y, Ito K, Kizawa Y, Failla M, Ito M, Kusama T, Elliott WM, Hogg JC, Adcock IM, Barnes PJ
(2010) Targeting phosphoinositide-3-kinase delta with theophylline reverses corticosteroid
insensitivity in COPD. Am J Respir Crit Care Med 182:897-904
Search WWH ::




Custom Search